| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $376.4M | +2.6% |
| Cost of Revenue | $205.3M | +1.1% |
| R&D Expense | $37.0M | -5.5% |
| SG&A Expense | $61.2M | -0.9% |
| Operating Income | -$74.9M | -159.4% |
| Pre-tax Income | -$64.8M | -31.8% |
| Income Tax | $1.7M | +100.7% |
| Net Income | -$66.6M | -33.0% |
| EPS (Basic) | -$0.89 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20.0M | -8.3% |
| Accounts Receivable | $68.5M | -5.0% |
| Current Assets | $104.8M | -3.9% |
| Total Assets | $580.6M | -12.5% |
| Current Liabilities | $165.1M | -0.2% |
| Total Liabilities | $248.5M | -1.5% |
| Stockholders' Equity | $144.2M | -35.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $34.9M | +254.5% |
| Capital Expenditures | $1.1M | +41.6% |
| Investing Cash Flow | -$17.8M | -21.7% |
| Financing Cash Flow | -$18.1M | +19.2% |
| Free Cash Flow | $33.8M | +273.4% |
| -14.1% |
| EPS (Diluted) | -$0.89 | -14.1% |